The genome-first approach inverts the traditional clinical paradigm. Instead of waiting for disease to manifest and then ordering targeted genetic tests, genome-first medicine begins with comprehensive genomic sequencing and uses the results to drive proactive clinical management. This approach identifies hereditary cancer risks, cardiac conditions, metabolic disorders, and pharmacogenomic variants before they cause harm.